BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2595729)

  • 1. Short-term tranexamic acid treatment in aneurysmal subarachnoid hemorrhage.
    Wijdicks EF; Hasan D; Lindsay KW; Brouwers PJ; Hatfield R; Murray GD; van Gijn J; Vermeulen M
    Stroke; 1989 Dec; 20(12):1674-9. PubMed ID: 2595729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytic treatment in subarachnoid hemorrhage.
    Vermeulen M; Lindsay KW; Murray GD; Cheah F; Hijdra A; Muizelaar JP; Schannong M; Teasdale GM; van Crevel H; van Gijn J
    N Engl J Med; 1984 Aug; 311(7):432-7. PubMed ID: 6379455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of tranexamic acid on rebleeding after subarachnoid hemorrhage: a double-blind controlled clinical trial.
    van Rossum J; Wintzen AR; Endtz LJ; Schoen JH; de Jonge H
    Ann Neurol; 1977 Sep; 2(3):238-42. PubMed ID: 365072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: a consecutive controlled clinical trial.
    Fodstad H; Forssell A; Liliequist B; Schannong M
    Neurosurgery; 1981 Feb; 8(2):158-65. PubMed ID: 7010203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm with tranexamic acid: a double-blind clinical trial.
    Chandra B
    Ann Neurol; 1978 Jun; 3(6):502-4. PubMed ID: 354483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifibrinolytic therapy in patients with aneurysmal subarachnoid hemorrhage. A report of the cooperative aneurysm study.
    Adams HP; Nibbelink DW; Torner JC; Sahs AL
    Arch Neurol; 1981 Jan; 38(1):25-9. PubMed ID: 7458720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antifibrinolytic drugs in aneurysmal subarachnoid hemorrhage.
    Schisano G
    Surg Neurol; 1978 Oct; 10(4):217-22. PubMed ID: 725719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tranexamic acid in subarachnoid hemorrhage. A double-blind study.
    Kaste M; Ramsay M
    Stroke; 1979; 10(5):519-22. PubMed ID: 505491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Preoperative management of patients with aneurysmal subarachnoid haemorrhage. A preliminary comparative study of consecutive and randomized series.
    Tovi D
    Acta Neurochir (Wien); 1975; 31(3-4):271. PubMed ID: 1181836
    [No Abstract]   [Full Text] [Related]  

  • 11. Preoperative management of patients with aneurysmal subarachnoid hemorrhage.
    Tovi D
    J Neurosurg Sci; 1975; 19(1-2):59-64. PubMed ID: 1221096
    [No Abstract]   [Full Text] [Related]  

  • 12. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
    Fodstad H; Liliequist B; Schannong M; Thulin CA
    Surg Neurol; 1978 Jul; 10(1):9-15. PubMed ID: 356311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.
    Hillman J; Fridriksson S; Nilsson O; Yu Z; Saveland H; Jakobsson KE
    J Neurosurg; 2002 Oct; 97(4):771-8. PubMed ID: 12405362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage.
    Vermeij FH; Hasan D; Bijvoet HW; Avezaat CJ
    Stroke; 1998 May; 29(5):924-30. PubMed ID: 9596236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage.
    Mendelow AD; Stockdill G; Steers AJ; Hayes J; Gillingham FJ
    Acta Neurochir (Wien); 1982; 62(3-4):195-202. PubMed ID: 7102384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study.
    Tsementzis SA; Hitchcock ER; Meyer CH
    Acta Neurochir (Wien); 1990; 102(1-2):1-10. PubMed ID: 2407050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrinolytic therapy in ruptured intracranial aneurysm through repeated monitoring of fibrinolytic activity of blood.
    Watanabe H; Ito M; Chigasaki H; Ishii S
    Neurol Med Chir (Tokyo); 1976; 16(PT1):91-6. PubMed ID: 66644
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome of aneurysmal subarachnoid hemorrhage in patients 66 years of age and older.
    Muizelaar JP; Vermeulen M; van Crevel H; Hijdra A; van Gijn J; Teasdale GM; Lindsay KW; Murray GD
    Clin Neurol Neurosurg; 1988; 90(3):203-7. PubMed ID: 3197345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged antifibrinolysis: an effective non-surgical treatment for ruptured intracranial aneurysms?
    Maurice-Williams RS
    Br Med J; 1978 Apr; 1(6118):945-7. PubMed ID: 346153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrinolytic treatment in subarachnoid hemorrhage: a randomized placebo-controlled trial. STAR Study Group.
    Roos Y
    Neurology; 2000 Jan; 54(1):77-82. PubMed ID: 10636129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.